A wide variety of phenolic compounds are constituents of the human diet. These include synthetic antioxidants, such as butylated hydroxytoluene (BHT) and butylated hydroxyanisole, together with naturally occurring substances such as vitamin E and hydroxylated flavonoids. Many of these produce diverse biochemical effects that range from tumor prevention to tumor initiation or promotion. Mutagenicity and cytotoxicity are also associated with certain dietary phenols. Much evidence indicates that phenols undergo metabolic activation to reactive species which can affect essential cellular processes. A common chemical feature of these compounds is their susceptibility to one-electron oxidation to produce phenoxy radicals. These radicals readily undergo further one-electron oxidation to quininoid species and also combine with molecular oxygen to produce hydroperoxy derivatives (peroxyquinols). This latter pathway has received very little attention, partly due to the high reactivity of peroxyquinols in biological systems, and also to a lack of knowledge concerning the transformation products formed. Cytochrome P-450 is a potent peroxidase, but its mechanism of action remains unclear. Studies have shown that BHT is converted to hydroperoxide in hepatic microsomes and that this peroxyquinol is rapidly degraded by P-450. Results of detailed product studies indicated the existance of three distinct pathways involving free radical formation, isomerization and electrophilic rearrangements. The proposed project will address three related issues, the role of hydroperoxide pathways in phenol metabolism, the mechanisms of cytochrome P-450 degradation of peroxyquinols and the relationships of these processes to phenol toxicity.
The specific aims are as follows. (1) Synthesize hydroperoxide derivatives of alkylated phenols, and (2) investigate mechanisms of the cytochrome P-450-catalyzed transformations of the hydroperoxides. Peroxyquinols of varying structures will be incubated with hepatic microsomes and purified P-450, and the products identified. This information will facilitate elucidation of the mechanisms involved. (3) Evaluate the contribution of hydroperoxide formation to the biotransformations of phenolic antioxidants and their analogs. (4) Investigate influences of enzyme origin on the formation and degradation of hydroperoxides. (5) Investigate the effects of peroxyquinols on lipid peroxidation, destruction of cytochrome P-450, oxidations of cosubstrates, and on biological macromolecules via covalent binding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA041248-01
Application #
3181533
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1986-03-01
Project End
1989-02-28
Budget Start
1986-03-01
Budget End
1987-02-28
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Colorado at Boulder
Department
Type
Schools of Pharmacy
DUNS #
City
Boulder
State
CO
Country
United States
Zip Code
80309
Shearn, Colin T; Fritz, Kristofer S; Thompson, John A (2011) Protein damage from electrophiles and oxidants in lungs of mice chronically exposed to the tumor promoter butylated hydroxytoluene. Chem Biol Interact 192:278-86
Shearn, Colin T; Fritz, Kristofer S; Meier, Brent W et al. (2008) Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro. Chem Res Toxicol 21:1631-41
Meier, Brent W; Gomez, Jose D; Kirichenko, Oleg V et al. (2007) Mechanistic basis for inflammation and tumor promotion in lungs of 2,6-di-tert-butyl-4-methylphenol-treated mice: electrophilic metabolites alkylate and inactivate antioxidant enzymes. Chem Res Toxicol 20:199-207
Meier, Brent W; Gomez, Jose D; Zhou, Angela et al. (2005) Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines. Chem Res Toxicol 18:1575-85
Lemercier, Jean-Noel; Meier, Brent W; Gomez, Jose D et al. (2004) Inhibition of glutathione S-transferase P1-1 in mouse lung epithelial cells by the tumor promoter 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT-quinone methide): protein adducts investigated by electrospray mass spectrometry. Chem Res Toxicol 17:1675-83
Sun, Yude; Dwyer-Nield, Lori D; Malkinson, Alvin M et al. (2003) Responses of tumorigenic and non-tumorigenic mouse lung epithelial cell lines to electrophilic metabolites of the tumor promoter butylated hydroxytoluene. Chem Biol Interact 145:41-51
Kupfer, Rene; Dwyer-Nield, Lori D; Malkinson, Alvin M et al. (2002) Lung toxicity and tumor promotion by hydroxylated derivatives of 2,6-di-tert-butyl-4-methylphenol (BHT) and 2-tert-butyl-4-methyl-6-iso-propylphenol: correlation with quinone methide reactivity. Chem Res Toxicol 15:1106-12
Kupfer, R; Liu, S Y; Allentoff, A J et al. (2001) Comparisons of hydroperoxide isomerase and monooxygenase activities of cytochrome P450 for conversions of allylic hydroperoxides and alcohols to epoxyalcohols and diols: probing substrate reorientation in the active site. Biochemistry 40:11490-501
Thompson, J A; Carlson, T J; Sun, Y et al. (2001) Studies using structural analogs and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion. Toxicology 160:197-205
Dwyer-Nield, L D; Thompson, J A; Peljak, G et al. (1998) Selective induction of apoptosis in mouse and human lung epithelial cell lines by the tert-butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion. Toxicology 130:115-27

Showing the most recent 10 out of 19 publications